Remus Pharmaceuticals informs NSE of non-applicability of Regulation 27(2) Corporate Governance reporting due to Regulation 15(2) exemption for its SME Emerge-listed equity shares.
AI Assistant
Remus Pharmaceuticals Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.